The data shows that expression of BCL9L protein was predominantly increased in dysplastic urothelium and MIBC compared to NMIBC and non-dysplastic urothelium, suggesting an association with aggressiveness and tumour stage of bladder cancer cells. This evidence concerns the gene BCL9L and urinary bladder carcinoma.